Table 3.

Adjusted Prevalence Odds Ratios for Three Outcomes: Evaluation of a Potential Interaction between Elevated Antiphospholipid Antibody Titers (EAAT) and Systemic Lupus Erythematosus (SLE)

	Outcomes
	Preeclampsia or Eclampsia		Placental Insufficiency		Prolonged length of stay
Risk Factor Group	Odds Ratio* [95% CI†]	P-value	Odds Ratio‡ [95% CI†]	P-value	Odds Ratio§ [95% CI†]	P-value
Has EAAT, and Has SLE (n = 5)	33.14 [5.29, 207.61]	0.0002	14.12 [1.58, 126.51]	0.018	9.68 [1.57, 59.87]	0.015
Has EAAT, No SLE (n = 83)	2.12 [0.98, 4.63]	0.058	4.06 [1.64, 10.03]	0.0025	3.72 [2.38, 5.83]	< 0.0001
No EAAT, Has SLE (n = 126)	3.29 [1.97, 5.52]	< 0.0001	4.61 [2.34, 9.09]	< 0.0001	3.69 [2.56, 5.31]	< 0.0001
No EAAT, and No SLE (n = 141,072)	1 [Reference]	--	1 [Reference]	--	1 [Reference]	--

* Adjusted for race, age, Medicaid status, diabetes, obesity, and primigravida status

^† CI = Confidence interval

^‡ Adjusted for race, age, and Medicaid status

^§ Adjusted for race, age, Medicaid status, and diabetes